| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2785497 | Current Opinion in Genetics & Development | 2006 | 8 Pages |
Abstract
Recent evidence continues to support a central role for TGFβ in tumor maintenance and progression. Although this may involve TGFβ-mediated paracrine effects that modulate the tumor microenvironment and the host immune system, some studies causally implicate autocrine TGFβ in cancer cell motility and survival. Other recent evidence indicates synergy between oncogene and TGFβ signaling in epithelial cell transformation. This suggests opportunities for dissecting molecular mechanisms of cross-talk as well as providing insights into possible combinatorial molecular anticancer therapies that will include TGFβ inhibitors.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Developmental Biology
Authors
Carlos L Arteaga,